West China Hospital: Carcinoma, Hepatocellular trials

The registry lists 14 Carcinoma, Hepatocellular studies with West China Hospital as lead sponsor. 12 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 6Phase 2 4Phase 3 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Surgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular CarcinomaNot yet recruitingNCT07866612Not applicable
• YMN-A02 for Advanced Primary Hepatocellular Carcinoma.Not yet recruitingNCT07580261Phase 1
• Surgery vs. Watch-and-Wait Strategy in Partial & Complete Responders for Hepatocellular CarcinomaRecruitingNCT07410715
• Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver ResectionRecruitingNCT07295275
• NIR-II Fluorescence-Guided Hepatectomy Using ICG-Cisplatin Nanoprobes for HCCRecruitingNCT07295262Early Phase 1
• A Study of GV20-0251 in Advanced or Refractory Solid TumorsRecruitingNCT07106827Phase 1
• WGc-0201 Plus Tislelizumab in HCC With High Risk of Recurrence and Metastasis After Radical TherapyNot yet recruitingNCT07077369Phase 1
• Application of mRNA Vaccine in Liver Transplantation for Hepatocellular CarcinomaRecruitingNCT07077356Phase 1
• JDB153 Combined With Penpulimab for Hepatocellular Carcinoma After Standard Treatment FailureNot yet recruitingNCT07075419Phase 1/2
• Textbook Outcomes of Right Hemihepatectomy in Patients With Hepatocellular CarcinomaRecruitingNCT06950827
• PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCCRecruitingNCT06742424Phase 2
• Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTTRecruitingNCT06664996Phase 2
• Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular CarcinomaStatus unknownNCT05738447Phase 1
• Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCCStatus unknownNCT05544253Phase 2/3